NAGE
Niagen Bioscience, Inc.
3.00$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.8% | -1.6% | -0.1% | +4.6% | +20.8% | +19.1% | +12.5% | +7.2% | +8.4% | +7.4% | -6.8% | |
| – | +5.0% | -1.1% | +0.7% | +5.7% | +23.0% | +18.9% | +13.7% | +8.0% | +3.4% | +8.6% | -7.0% | |
| – | +2.1% | +0.9% | +1.2% | +16.3% | +38.0% | +24.6% | +8.8% | +6.3% | +1.0% | +2.7% | +0.3% | |
| – | +2.1% | +0.9% | +1.2% | +16.3% | +38.0% | +24.6% | +8.8% | +6.3% | +1.0% | +2.7% | +0.3% | |
| – | -6.6% | +26.2% | +18.4% | -9.2% | +9.5% | -9.2% | +36.9% | -11.9% | +14.5% | +34.2% | -34.3% | |
| – | +15.1% | -14.0% | -7.9% | -8.4% | -12.8% | +21.7% | +28.8% | +30.4% | +8.7% | +17.6% | -14.1% | |
| – | -7.6% | -7.5% | -7.8% | -8.7% | -9.6% | -10.3% | -11.8% | -13.4% | +2,200.8% | -3.1% | -3.2% | |
| – | +1.3% | -5.2% | -7.2% | -5.0% | +0.1% | +17.2% | +5.1% | +0.5% | +8.8% | +7.1% | -24.8% | |
| – | +6.1% | -5.7% | -8.1% | -0.9% | +1.4% | +16.1% | +7.2% | +1.7% | -12.3% | +14.6% | -34.1% | |
| – | -18.8% | +22.6% | +14.4% | +3.6% | -2.5% | -4.6% | +1.6% | +1.6% | +2.5% | +3.0% | -11.1% | |
| – | +11.2% | -22.8% | +2.6% | -14.8% | +23.5% | +24.7% | +28.7% | -6.9% | -15.3% | +23.0% | -28.9% | |
| – | +4.2% | +1.7% | +6.1% | +11.9% | +34.1% | +20.1% | +16.0% | +10.1% | +8.3% | +7.6% | +0.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.2% | +0.4% | +2.9% | +5.0% | +1.9% | +3.6% | +0.4% | -2.5% | +0.1% | -2.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.